Perfil
Jason D.
Fontenot served as the Chief Scientific Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2021 to 2024.
Prior to that, he was the Chief Scientific Officer at Immusoft Corp.
from 2018 to 2019.
Before joining Immusoft Corp., he worked as the Head-Exploratory Research at Juno Therapeutics, Inc. from 2016 to 2018.
Mr. Fontenot holds a doctorate degree from the University of Washington.
Antiguos cargos conocidos de Jason Fontenot.
| Empresas | Cargo | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 02/01/2024 |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Director Técnico/Científico/I+D | 01/03/2019 |
| JUNO THERAPEUTICS INC | Director Técnico/Científico/I+D | 01/01/2018 |
Formación de Jason Fontenot.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Provides disease curing services through immune cells | Health Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
- Bolsa de valores
- Insiders
- Jason Fontenot
















